BMC Nephrology

Table 1 Baseline characteristics of the KIDNEES cohort free of Atherosclerotic Cardiovascular Disease at baseline (n = 398,477) (pooled imputed data)

From: Cardiovascular events and mortality in chronic kidney disease in primary care patients with previous type 2 diabetes and/or hypertension. A population-based epidemiological study (KIDNEES)

		CKD without HTN/T2D	CKD with HTN	CKD with T2D	CKD with HTN/T2D	p-value
Age (years)		70 [58, 80]	76 [68, 82]	69 [57, 78]	74 [65, 80]	< 0.001
Age (years, cat.)	< 65	39.74	20.61	42.61	25.30	< 0.001
	(65, 80)	37.01	47.97	38.19	51.22
	≥ 80	23.24	31.42	19.20	23.48
Sex	Female	56.55	59.03	38.94	50.27	< 0.001
MEDEA deprivation index	Rural	24.43	25.52	23.40	24.53	< 0.001
	Least deprived quintile	18.13	16.07	13.35	12.91
	Second quintile	16.05	15.34	15.11	14.27
	Third quintile	14.95	15.36	14.57	15.53
	Forth quintile	13.90	14.57	15.87	16.27
	Most deprived quintile	12.54	13.14	17.70	16.49
Expanded CHARLSON INDEX SCORE	Non comorbidity	64.57	68.31	54.05	51.05	< 0.001
	Low	29.38	26.47	34.88	37.08
	High	6.05	5.21	11.08	11.87
Opht/ neur complications		0.07	0.27	10.33	13.53	< 0.001
Hypertensive heart disease		0.00	2.71	0.00	3.16	< 0.001
Other specified kidney diseases		3.43	2.28	2.32	2.09	< 0.001
Autoimmune Disease with CKD risk		0.59	0.34	0.38	0.20	< 0.001
Smoking status	Non smoker	66.20	72.30	53.90	65.28	< 0.001
	Smoker	17.10	11.37	23.47	13.54
	Former smoker	16.70	16.34	22.63	21.18
Obesity	Underweight	1.53	0.42	0.63	0.16	< 0.001
	Normal	31.64	17.78	20.22	11.85
	Overweight	43.64	43.31	43.21	38.72
	Class 1 obesity	17.96	27.41	25.16	31.29
	Class 2/3 obesity	5.23	11.08	10.78	17.98
Heart Failure		4.60	6.02	6.42	7.83	< 0.001
Atrial Fibrillation		6.97	9.83	8.10	10.49	< 0.001
Hypercholesterolemia		44.20	43.29	29.23	27.36	< 0.001
Systolic blood pressure	≥ 140 mm Hg	14.93	37.03	16.78	42.95	< 0.001
Diastolic blood pressure	≥ 90 mm Hg	4.83	9.81	4.06	9.74	< 0.001
Anemia		17.10	18.04	20.66	24.29	< 0.001
Statins		30.91	41.49	49.50	59.70	< 0.001
Platelet / Anticoagulant		22.64	32.40	38.54	51.57	< 0.001
Angiotensin-converting enzyme inh.		12.63	57.18	23.42	63.59	< 0.001
Angiotensin II receptor antagonists		7.09	36.01	11.84	43.37	< 0.001
Aldosterone antagonists		4.21	4.06	6.82	5.89	< 0.001

Back to article page

ISSN: 1471-2369

Contact us

Submission enquiries: bmcnephrology@biomedcentral.com
General enquiries: ORSupport@springernature.com